Handelsbanken Fonder AB Has $2.10 Million Stock Holdings in Chemed Co. (NYSE:CHE)

Handelsbanken Fonder AB increased its position in Chemed Co. (NYSE:CHEFree Report) by 2.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,972 shares of the company’s stock after purchasing an additional 100 shares during the quarter. Handelsbanken Fonder AB’s holdings in Chemed were worth $2,104,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. HighTower Advisors LLC lifted its stake in Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock valued at $2,246,000 after buying an additional 1,634 shares during the period. XTX Topco Ltd raised its position in shares of Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company’s stock valued at $1,709,000 after acquiring an additional 1,499 shares during the period. Geode Capital Management LLC boosted its stake in Chemed by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock worth $201,820,000 after acquiring an additional 15,791 shares during the last quarter. Signal Advisors Wealth LLC grew its holdings in Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after purchasing an additional 1,886 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Chemed by 8.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company’s stock valued at $73,792,000 after purchasing an additional 9,178 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Price Performance

CHE opened at $551.28 on Wednesday. The company has a market capitalization of $8.30 billion, a price-to-earnings ratio of 27.86, a P/E/G ratio of 2.15 and a beta of 0.48. The business’s 50-day moving average price is $543.28 and its two-hundred day moving average price is $563.22. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s dividend payout ratio is presently 10.11%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Royal Bank of Canada lowered their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Read Our Latest Research Report on CHE

Insider Buying and Selling

In other Chemed news, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction dated Monday, December 30th. The stock was bought at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 3.32% of the stock is currently owned by corporate insiders.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.